Skip to content

Gilead Sciences GILD Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Gross margin79.4%+0.5pp78.8%+0.1pp78.7%+0.2pp78.5%+0.2pp78.3%0.0pp
Operating margin34.9%+0.8pp34%-2.0pp36.1%+8.2pp27.9%-0.7pp28.6%+22.8pp
Net margin31%+2.1pp28.9%+1.0pp27.9%+6.0pp21.9%+1.1pp20.8%+19.1pp
Returns
Return on equity43.2%+2.7pp40.5%0.0pp40.5%+7.3pp33.3%+0.7pp32.5%+30.2pp
Return on invested capital23.7%+1.5pp22.2%-0.5pp22.7%+4.7pp18%-1.4pp19.4%+16.4pp
Efficiency
Asset turnover0.5×0.0×0.5×0.0×0.5×0.0×0.5×0.0×0.5×0.0×
Liquidity
Current ratio+0.4×1.6×+0.1×1.5×+0.1×1.3×-0.1×1.4×-0.2×
Leverage
Debt-to-equity0.9×-0.2×1.1×0.0×1.2×-0.1×1.3×0.0×1.3×-0.1×
Net debt / EBITDA1.4×-0.4×1.7×+0.1×1.6×-0.7×2.3×+0.4×-6.5×
Per Share
Book value per share$18.75+3.7%$18.09+5.3%$17.18+9.6%$15.68+3.0%$15.22-1.2%
Valuation
Market capitalization$172.99B+13.6%$152.28B+10.6%$137.73B+3.3%$133.35B-4.5%$139.69B+21.3%
Price / earnings18.8×+0.9×17.9×+0.9×17×-4.1×21.1×-2.3×23.4×-216×
Price / sales5.8×+0.6×5.2×+0.4×4.7×+0.1×4.6×-0.2×4.9×+0.9×
Price / book7.4×+0.6×6.7×+0.3×6.4×-0.4×6.8×-0.5×7.3×+1.3×
EV / EBITDA17.5×+1.1×16.4×+2.1×14.3×-3.9×18.2×0.0×18.2×-46.6×
Dividend yield2.3%-0.3pp2.6%-0.3pp2.9%-0.1pp3%+0.2pp2.8%-0.6pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Gilead Sciences's profit margins?
Gilead Sciences (GILD) runs a 79.4% gross margin and a 34.9% operating margin, with a 31.0% net margin.
Where do Gilead Sciences's ratios come from?
Every ratio is computed from Gilead Sciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.